Raptor Pharmaceutical Corp (RPTP)

9.00
0.00 (0.00)
NASDAQ : Health Care
Prev Close 9.00
Open 8.95
Day Low/High 8.95 / 9.05
52 Wk Low/High 2.94 / 14.90
Volume 753.41K
Avg Volume 2.45M
Exchange NASDAQ
Shares Outstanding 85.31M
Market Cap 767.76M
EPS -0.80
P/E Ratio N/A
Div & Yield N.A. (N.A)
Trade-Ideas: Raptor Pharmaceutical (RPTP) Is Today's Strong On High Relative Volume Stock

Trade-Ideas: Raptor Pharmaceutical (RPTP) Is Today's Strong On High Relative Volume Stock

Trade-Ideas LLC identified Raptor Pharmaceutical (RPTP) as a strong on high relative volume candidate

Commit To Purchase Raptor Pharmaceuticals At $7.50, Earn 33.3% Using Options

Commit To Purchase Raptor Pharmaceuticals At $7.50, Earn 33.3% Using Options

Investors considering a purchase of Raptor Pharmaceuticals Corp. shares, but tentative about paying the going market price of $9.32/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Insider Trading Alert - RPTP, TEAR And ISRG Traded By Insiders

Insider Trading Alert - RPTP, TEAR And ISRG Traded By Insiders

Stocks with insider trader activity include RPTP, TEAR and ISRG

RPTP Makes Bullish Cross Above Critical Moving Average

RPTP Makes Bullish Cross Above Critical Moving Average

In trading on Thursday, shares of Raptor Pharmaceuticals Corp. crossed above their 200 day moving average of $11.00, changing hands as high as $11.05 per share.

Strong On High Relative Volume: Raptor Pharmaceutical (RPTP)

Strong On High Relative Volume: Raptor Pharmaceutical (RPTP)

Trade-Ideas LLC identified Raptor Pharmaceutical (RPTP) as a strong on high relative volume candidate

Today's Weak On High Volume Stock: Raptor Pharmaceutical (RPTP)

Today's Weak On High Volume Stock: Raptor Pharmaceutical (RPTP)

Trade-Ideas LLC identified Raptor Pharmaceutical (RPTP) as a weak on high relative volume candidate

Interesting RPTP Put And Call Options For October 18th

Interesting RPTP Put And Call Options For October 18th

Investors in Raptor Pharmaceuticals Corp. saw new options become available this week, for the October 18th expiration.

Ratings Changes Today

Upgrades: AMOT, CCL, CSIQ, IEP, KRO, MNDL, STRL, WTW Downgrades: RGP Initiations: NYLD, OMED, ORM, RPTP, UCP Read on to get TheStreet Quant Ratings' detailed report:

Why Raptor Is Down, Despite Possibility of New Drug Approval

Why Raptor Is Down, Despite Possibility of New Drug Approval

Raptor released positive phase 3 data for its Huntington's treatment in February, but since then little has happened. The share price is now depressed, presenting a good entry point.

Why Raptor Pharmaceuticals (RPTP) Stock Is Gaining Today

Why Raptor Pharmaceuticals (RPTP) Stock Is Gaining Today

Raptor Pharmaceuticals (RPTP) is gaining Friday after beating analysts' estimates for earnings and revenue in the second quarter and raising its sales guidance for the year.

Raptor Receives Orphan Drug Designation For Cysteamine Bitartrate In Huntington's Disease From The European Commission

Raptor Receives Orphan Drug Designation For Cysteamine Bitartrate In Huntington's Disease From The European Commission

Orphan Designation Provides 10 Years of EU Market Exclusivity Upon Approval

First Week of RPTP September 20th Options Trading

First Week of RPTP September 20th Options Trading

Investors in Raptor Pharmaceuticals Corp. saw new options become available this week, for the September 20th expiration.

3 Stocks Spiking on Unusual Volume

3 Stocks Spiking on Unusual Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

Raptor Pharmaceutical Enters Into $70 Million Financing Transaction And Amended Loan Agreement With HealthCare Royalty Partners

Raptor Pharmaceutical Enters Into $70 Million Financing Transaction And Amended Loan Agreement With HealthCare Royalty Partners

Financing Includes $60 Million 8% Notes Convertible at $17.50 Per Share, and $10 Million Additional Funding Pursuant to a Revised Synthetic Royalty(R) Loan Agreement

Interesting RPTP Put And Call Options For February 2015

Interesting RPTP Put And Call Options For February 2015

Investors in Raptor Pharmaceuticals Corp. saw new options begin trading this week, for the February 2015 expiration.

3 Stocks Under $10 Moving Higher

3 Stocks Under $10 Moving Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.